Opportunity Information: Apply for RFA AG 12 009
Apply for RFA AG 12 009
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "T1 Translational Research on Aging Small Business Innovation Awards (R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866 Aging Research.
- This funding opportunity was created on Aug 4, 2011 and posted on Aug 4, 2011.
- Applicants must submit their applications by Nov 4, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "T1 Translational Research on Aging Small Business Innovation Awards (R43/R44)" (Funding Opportunity Number RFA-AG-12-009) is a discretionary National Institutes of Health (NIH) funding program designed to move aging-related scientific discoveries closer to real-world use. Its central purpose is to accelerate translation, meaning it supports work that takes promising research findings and turns them into practical, scalable solutions that can be developed, validated, and ultimately commercialized to help older adults maintain health, function, and independence. The program is aimed at strengthening the role of small businesses as engines of innovation, since companies are often positioned to package research into products and services that can actually reach clinics, communities, caregivers, and consumers.
This funding announcement supports Small Business Innovation Research (SBIR) grants using the R43 and R44 mechanisms, which generally correspond to phased development. In practice, this structure is commonly used to help a small business move from early feasibility and proof-of-concept activities toward more advanced research and development steps that position an innovation for commercialization. The FOA explicitly emphasizes innovations that have both a strong likelihood of benefiting older adults and a realistic path to commercial success, meaning applicants are expected to think beyond basic science and demonstrate a credible plan for development, adoption, and market impact. The types of innovations envisioned are broad and can include novel devices, products, healthcare practices, and programs, as long as they are meaningfully connected to aging and have translational potential.
The activity area is health, with the CFDA listing under 93.866 (Aging Research). Eligibility is limited to small businesses, reinforcing the program's intent to mobilize private-sector capabilities in product development, regulatory planning where relevant, manufacturing considerations, usability testing, implementation strategies, and go-to-market preparation. The announcement also indicates there is no cost-sharing or matching requirement, which lowers barriers for early-stage companies that may not have extensive capital.
From an administrative standpoint, the opportunity was posted and created on August 4, 2011, with an original and current closing date of November 4, 2011, and it was archived on December 5, 2011. The estimated total funding amount listed for the program is $2,000,000. The sponsoring agency is the National Institutes of Health, and the full announcement was made available through the NIH grants guide at http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-12-009.html. For access or technical issues related to the online announcement, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV, including support for difficulties accessing the FOA electronically or problems linking to the announcement.
Overall, this FOA is best understood as a targeted SBIR initiative in translational aging research: it is not primarily about generating new basic knowledge, but about supporting small businesses in building and testing innovations that can realistically be brought to market and used to improve health outcomes and functional independence for older adults.
Frequently Asked Questions (FAQs)
What is the official title of this grant opportunity?
The official title is "T1 Translational Research on Aging Small Business Innovation Awards (R43/R44)."
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is RFA-AG-12-009.
Which federal agency is sponsoring this funding opportunity?
The sponsoring agency is the National Institutes of Health (NIH).
What is the main purpose of this SBIR funding opportunity?
The central purpose is to accelerate translation in aging research by helping small businesses move promising aging-related scientific discoveries closer to real-world use. The focus is on developing practical, scalable solutions that can be developed, validated, and ultimately commercialized to help older adults maintain health, function, and independence.
Is this opportunity focused on basic science or on translational development?
This opportunity is described as a targeted SBIR initiative in translational aging research. It is not primarily aimed at generating new basic knowledge; it is intended to support development and testing of innovations that can realistically be brought to market and used to improve outcomes for older adults.
What grant mechanisms does this program use?
This announcement supports Small Business Innovation Research (SBIR) grants using the R43 and R44 mechanisms.
How should applicants think about the R43 and R44 structure?
The R43/R44 structure generally corresponds to phased development. It is commonly used to help a small business move from early feasibility and proof-of-concept activities toward more advanced research and development steps that position an innovation for commercialization.
Who is eligible to apply?
Eligibility is limited to small businesses.
Why does the FOA limit eligibility to small businesses?
The opportunity is designed to strengthen the role of small businesses as engines of innovation, since companies are often positioned to package research into products and services that can reach clinics, communities, caregivers, and consumers.
What topic area or discipline does this opportunity fall under?
The activity area is health, with the CFDA listing under 93.866 (Aging Research).
What kinds of projects or innovations does the FOA encourage?
The FOA envisions a broad range of aging-related innovations with translational potential, including novel devices, products, healthcare practices, and programs, as long as they are meaningfully connected to aging and aimed at real-world use.
What outcomes or impacts is this funding trying to support for older adults?
The program emphasizes innovations that can help older adults maintain health, function, and independence, with the expectation that successful projects move toward real-world adoption and use.
Does the FOA emphasize commercialization?
Yes. The announcement explicitly emphasizes innovations that have both a strong likelihood of benefiting older adults and a realistic path to commercial success. Applicants are expected to think beyond basic science and present a credible plan for development, adoption, and market impact.
What kinds of development considerations are relevant under this FOA?
The opportunity is intended to mobilize private-sector capabilities tied to product development, including areas such as regulatory planning (where relevant), manufacturing considerations, usability testing, implementation strategies, and go-to-market preparation.
Is cost-sharing or matching required?
No. The announcement indicates there is no cost-sharing or matching requirement.
What is the estimated total funding amount listed for the program?
The estimated total funding amount listed is $2,000,000.
When was this opportunity posted and created?
It was posted and created on August 4, 2011.
What was the closing date for this funding opportunity?
The original and current closing date listed is November 4, 2011.
Is this FOA still active?
No. The opportunity was archived on December 5, 2011.
Where can applicants find the full announcement text?
The full announcement was made available through the NIH grants guide at http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-12-009.html.
Who should be contacted for technical problems accessing the announcement online?
For access or technical issues related to the online announcement (such as difficulty accessing the FOA electronically or problems linking to the announcement), the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
What does "T1 translational research" mean in the context provided?
In the context provided, "T1 translational research" refers to work that takes promising aging-related research findings and advances them toward practical, scalable solutions that can be developed, validated, and moved toward commercialization for real-world use.
What types of end users are implied for the innovations supported by this FOA?
The opportunity describes innovations that can ultimately reach real-world settings and users, including clinics, communities, caregivers, and consumers.
Browse more business programs for Business Consultants, Business Innovation
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: GBI Cultural Survey Monitoring
Previous opportunity: T2 Translational Research on Aging Small Business Innovation Awards (R43/R44)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 12 009
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 12 009) also looked into and applied for these:
| Funding Opportunity |
|---|
| 2012 NIH Directors Pioneer Award Program (DP1) Apply for RFA RM 11 004 Funding Number: RFA RM 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Demonstration Projects for Systems Biology of Aging in Saccharomyces cerevisiae (R01) Apply for RFA AG 12 011 Funding Number: RFA AG 12 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory/Developmental Projects in Translational Research (R21) Apply for PAR 11 293 Funding Number: PAR 11 293 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NINDS Cooperative Program in Translational Research Single Component Research Projects (U01) Apply for PAR 11 294 Funding Number: PAR 11 294 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Cooperative Program in Translational Research Multi Component Research Projects (U54) Apply for PAR 11 295 Funding Number: PAR 11 295 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Cooperative Program in Translational Research Small Business Awards (U44) Apply for PAR 11 296 Funding Number: PAR 11 296 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Research Resource for Systematic Reviews of Complementary and Alternative Medicine Clinical Trials (R24) Apply for RFA AT 12 001 Funding Number: RFA AT 12 001 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| RG 08092011 Demo1 Title Apply for RG 0892011 S2S D1 Funding Number: RG 0892011 S2S D1 Agency: IVV Test Agency Category: Health Funding Amount: Case Dependent |
| Molecular and Cellular Substrates of Complex Brain Disorders (R01) Apply for PAR 11 299 Funding Number: PAR 11 299 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Molecular and Cellular Substrates of Complex Brain Disorders (R21) Apply for PAR 11 300 Funding Number: PAR 11 300 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Mentored Career Award for Faculty at Institutions That Promote Diversity (K01) Apply for RFA HL 12 029 Funding Number: RFA HL 12 029 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| International Centers of Excellence for Malaria Research (ICEMR) Competitive Revision (U19) Apply for RFA AI 11 046 Funding Number: RFA AI 11 046 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| 2012 NIH Directors New Innovator Award Program (DP2) Apply for RFA RM 11 005 Funding Number: RFA RM 11 005 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Dimensional Approaches to Research Classification in Psychiatric Disorders (R01) Apply for RFA MH 12 100 Funding Number: RFA MH 12 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Emerging Infections Program Apply for CDC RFA CK12 1202 Funding Number: CDC RFA CK12 1202 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Discovery of Genetic Basis of Mendelian or Monogenic Heart, Lung, and Blood Disorders (X01) Apply for PAR 11 307 Funding Number: PAR 11 307 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Native American Research Centers for Health (NARCH) V and VI Competitive Supplements Apply for HHS 2011 IHS NARCH 0001 Funding Number: HHS 2011 IHS NARCH 0001 Agency: Indian Health Service Category: Health Funding Amount: $700,000 |
| Secondary Analysis of Existing Alcohol Epidemiology Data (R01) Apply for PA 11 308 Funding Number: PA 11 308 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analysis of Existing Alcohol Epidemiology Data (R03) Apply for PA 11 309 Funding Number: PA 11 309 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tribal Self Governance Program, Planning Cooperative Agreement Apply for HHS 2011 IHS TSGP 0001 Funding Number: HHS 2011 IHS TSGP 0001 Agency: Indian Health Service Category: Health Funding Amount: $75,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 12 009", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.